New Dems Urge House Leadership to Move Bipartisan Drug Pricing Bills
WASHINGTON – Members of the New Democrat Coalition’s Healthcare Task Force asked the House leadership on Wednesday to hold a floor vote on drug pricing bills with bipartisan support as early as next week.
The request was made in a letter sent to House Speaker Nancy Pelosi, Majority Leader Steny Hoyer, Majority Whip Jim Clyburn, and Assistant Leader Ben Ray Luján.
In it, Representatives Angie Craig, of Minnesota, Kurt Schrader, of Oregon, Kim Schrier, of Washington, and Greg Stanton, of Arizona, say while they support efforts to stabilize and expand on the Affordable Care Act, their constituents are demanding action be taken soon to curb the rising costs of prescription drugs.
The task force members ask the House leaders to consider bringing the bipartisan drug pricing bills included in H.R. 987, the Strengthening Health Care and Lowering Prescription Drug Costs Act, to the floor in a standalone package for a vote next week when other healthcare measures are expected to be considered.
“Each of the drug pricing bills in H.R. 987 had bipartisan support when introduced, as well as through the Committee process,” the representatives say.
“While we were optimistic our Republican colleagues would support commonsense fixes to strengthen the ACA, this comprehensive package was passed out of the House with only Democratic support,” they continue. “Consequently, our colleagues in the Senate have yet to vote on these noncontroversial drug pricing measures and send them to the President for enactment.”
The representatives note that at least three bills in the package would have an immediate moderating effect on prescription drug prices.
These include H.R. 965, the CREATES Act, introduced by Representative David Cicilline, of Rhode Island; H.R. 938, the BLOCKING Act, introduced by Representative Kurt Schrader, of Oregon; and H.R. 1499, the Protecting Consumer Access to Generic Drugs Act, introduced by Representative Bobby Rush, of Illinois.
The New Democrat Coalition members closed by reminding the House leaders and their colleagues across the aisle that “the rising cost of prescription drugs remains of paramount concern to all members, irrespective of political affiliation.
“There are families in every single congressional district struggling to pay for their prescription drugs. As such, this challenge calls for a unified approach. Respectfully, we urge leadership to bring these bipartisan measures to the floor and, in doing so, reiterate our commitment to tackling the rising cost of prescription drugs in a bipartisan manner before the August recess,” the members say.
In The News
WASHINGTON — President Donald Trump contradicted one of his administration’s top scientists and announced Wednesday that widespread distribution of a coronavirus vaccine would begin as early as next month, further rattling the scientific and public health communities and stoking rival Joe Biden’s claim that Trump can’t... Read More
WASHINGTON -- Congress discussed proposals Wednesday to switch the United States to 100% clean energy as Western governors confronting out-of-control wildfires demand action on global warming. A House Energy and Commerce subcommittee is trying to figure out a way to recover jobs lost during the coronavirus... Read More
NEW YORK, N.Y.- The City of New York on Monday implemented a new COVID "Response Team" to monitor the city's schools and hopefully prevent a resurgence of the coronavirus in one of the nation's hardest hit municipalities. The city's new COVID Response Situation Room is a... Read More
WASHINGTON — Speaker Nancy Pelosi on Tuesday headed a call from her members to commit to keeping the House in session until there’s a coronavirus relief deal, but the vow does little to break the stalemate in bipartisan negotiations that is at the heart of Democrats’... Read More
WASHINGTON - Today, the House of Representatives passed the Strength in Diversity Act 2020, legislation that will provide funding for voluntary desegregation initiatives across the country. The Strength in Diversity Act was brought to the House by Rep. Marcia Fudge, D-Ohio, and authored by Rep. Robert... Read More
WASHINGTON — If the United States has even a typical flu season that collides with a COVID-19 flare, the resulting public health nightmare could swamp the nation’s already strained health system. This year’s flu season could be milder than usual because of social distancing. And more... Read More